There are many ways to design studies to test this, but the core of the question is whether GLP-1s are able to dramatically expand the number of patients that will accept treatment
Various studies have pointed toward GLP-1 RAs causing mental health complications, such as anxiety and depression
Weight, glucose parameters, and adverse effect assessment inform protocol adjustments
Making a Transition Transitioning from a compounded to an FDA-approved GLP-1 medication should be done under the guidance of a health care professional, Alyssa Billingsley, PharmD, director of pharmacy content at GoodRx, said, noting that such an individual can help the patient navigate any changes to the formulation, concentration, dosage, or delivery method
Overall, anti-metabolic drugs performed the best in both aspects, with odds ratios of 2.15 and 1.35, while anti-fibrotic drugs showed ratios of 0.86 and 1.11